Transcriptome analysis revealed that preventive GTE treatment affects several pathways associated with anti-obesity regulation, including activation of STAT and downregulation of CEBP signaling pathways. The gene discussed is SOAT1; the disease is obesity due to melanocortin 4 receptor deficiency.